- ￥1700 - 5450
- Absin
- abs190811
- 上海
- 2025年08月21日
- Blocking of RANKL signaling Functional assays
- Human
- 见优宁维官网
企业认证
相关产品推荐更多 >
Rabbit anti-AIFM2 Polyclonal Antibody【兔抗AIFM2多克隆抗体】
询价
active YAP1 Recombinant Rabbit mAb (S-516-142)【活性Yes相关蛋白1（YAP1）重组兔单克隆抗体（S - 516 - 142）】
￥600
S-RMab® E-Cadherin Recombinant Rabbit mAb (SDT-438-5)【S - RMab® E - 钙黏蛋白重组兔单克隆抗体（SDT - 438 - 5）】
￥600ULK2 Antibody【ULK2抗体】
询价
Rabbit anti-KCNIP3 Polyclonal Antibody【兔抗KCNIP3多克隆抗体】- abs151602
￥1600
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
Anti-CD254 Monoclonal mAb(DenosumAb)
- 抗体英文名：
Anti-CD254 Monoclonal Antibody(Denosumab)
- 靶点：
见优宁维官网
- 浓度：
2 mg/mL
- 应用范围：
Blocking of RANKL signaling Functional assays
- 宿主：
Human
- 适应物种：
见优宁维官网
- 保质期：
见优宁维官网
- 抗原来源：
见优宁维官网
- 级别：
优级
- 库存：
999
- 供应商：
Absin
- 标记物：
Unlabeled
- 克隆性：
S-SC009
- 保存条件：
Store at 4°C for one year. Avoid repeated freeze/thaw cycles.
- 免疫原：
见优宁维官网
- 规格：
10mg/5mg/1mg
| 规格： | 10mg | 产品价格： | 询价 |
|---|---|---|---|
| 规格： | 5mg | 产品价格： | ￥5450.0 |
| 规格： | 1mg | 产品价格： | ￥1700.0 |
别名：抗CD254单克隆抗体（地舒单抗）
免疫原：见优宁维官网
应用：Blocking of RANKL signaling Functional assays
保持条件：Store at 4°C for one year. Avoid repeated freeze/thaw cycles.
使用方法：Functional/Block/Neutralize
标记：Unlabeled
宿主：Human
反应种属：见优宁维官网
克隆性：S-SC009
产品描述：见优宁维官网
爱必信品牌介绍：
更多详情请了解优宁维网站》》
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The Application of Monoclonal Antibodies in the Treatment of Lymphoma
lymphoma treated with a chimeric anti-CD20 mAb, and Maloney and co-workers (2 ) recently reported a 50% response rate in relapsed, low-grade, NHL, with a 10---11 mo duration. Encouragingly, patients in these studies did not raise antibody responses
Isolation of Human Monoclonal Antibodies Using Guided Selection with Mouse Monoclonal Antibodies
Repertoires of antibody (Ab) V genes derived from nonimmunized human donors (1 ) or made synthetically (2 3 ) have been cloned for display on filamentous bacteriophage as either scFvs or Fabs fused to the minor phage coat protein (pIII
monoclonal antibodies have improved responses with minimal toxicities. For instance, Rituximab (chimeric anti-CD20 monoclonal antibody) was the first FDA-approved monoclonal antibody for the treatment of patients with non-Hodgkin’s lymphoma (NHL
技术资料暂无技术资料 索取技术资料
